FDA Inspection 1209618 — Catalyst Pharmaceuticals, Inc.
The FDA completed an inspection of Catalyst Pharmaceuticals, Inc. on June 22, 2023 in Coral Gables, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 22, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Coral Gables, FL (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)